The GPIIIa (β3 integrin) PlA polymorphism in the early development of coronary atherosclerosis

Atherosclerosis

Volumn 154, Issue 3, 2001, Pages 721-727

  Mikkelsson, Jussi ^a   Perola, Markus ^b   Penttilä, Antti ^c   Goldschmidt Clermont, Pascal J ^d   Karhunen, Pekka J ^a,e  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Atherosclerosis; Blood platelets; Coronary disease; Genetics; Integrins; Platelet glycoprotein GPIIb IIIa complex; Polymorphism

Indexed keywords

BETA3 INTEGRIN; FIBRINOGEN RECEPTOR; VITRONECTIN RECEPTOR; LEUKOCYTE ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY THROMBOSIS; ENDOTHELIUM; FINLAND; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE AGGREGATION; VASCULAR SMOOTH MUSCLE; CADAVER; CORONARY ARTERY DISEASE; GENE FREQUENCY; GENETICS; HOMOZYGOTE; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ALLELES; ANTIGENS, CD; CADAVER; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; GENE FREQUENCY; GENOTYPE; HOMOZYGOTE; HUMANS; INTEGRIN BETA3; MALE; MIDDLE AGED; PLATELET MEMBRANE GLYCOPROTEINS; POLYMORPHISM, GENETIC;

EID: 0035864341     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00683-3     Document Type: Article

References (57)

1. The pathogenesis of atherosclerosis: A perspective for the 1990s
2. Vascular endothelium. An integrator of pathophysiological stimuli in atherogenesis
3. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries
4. Endothelial dysfunction in hypertension
5. Cigarette smoking and endothelial injury: A review
6. Endothelium and acute coronary syndromes
7. β3-Integrins rather than β1-integrins dominate integrin-matrix interactions involved in postinjury smooth muscle cell migration
8. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium
9. αvβ3 integrin expression in normal and atherosclerotic artery
10. Function and regulation of the β3 integrins in hemostasis and vascular biology
11. β3 Integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells
12. Integrins and vascular extracellular matrix assembly
13. Stimulation of migration of human aortic smooth muscle cells by vitronectin: Implications for atherosclerosis
14. Coronary atherosclerosis: A multifactorial disease
15. The pathogenesis of coronary artery disease and the acute coronary syndromes
16. Aggregating human platelets stimulate the expression of thrombin receptors in cultured vascular smooth muscle cells via the release of transforming growth factor-β1 and platelet-derived growth factor AB
17. Aggregating human platelets stimulate expression of vascular endothelial growth factor in cultured vascular smooth muscle cells through a synergistic effect of transforming growth factor-β1 and platelet-derived growth factor AB
18. A alloantigens on human integrin β3
19. Increased platelet sensitivity related to the GPIIIa polymorphism (HPA-1b/PlA2)
20. A2 polymorphism
21. A2 polymorphism
22. b) positive platelets in patients with cardiovascular disease
23. A polymorphisms display different sensitivities to agonists
24. A2 polymorphism and thromboembolic events: From inherited risk to pharmacogenetics
25. 3 integrin enhances outside-in signaling and adhesive functions
26. A polymorphism in young men with myocardial infarction
27. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis
28. A2) is an inherited risk factor for premature myocardial infarction in coronary artery disease
29. Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population
30. Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease
31. Prothrombotic genetic risk factors in young survivors of myocardial infarction
32. A polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly
33. Genetic risk factors in acute coronary syndromes
34. A1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis
35. A2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM study
36. A2 polymorphism of platelet glycoprotein IIIa and premature myocardial infarction
37. Inherited platelet glycoprotein polymorphisms and a risk for coronary heart disease in young central Europeans
38. Genetic polymorphism of platelet glycoprotein IIIa in patients with acute myocardial infarction and acute ischemic stroke
39. Lipoprotein(a) and the significance of the association between platelet glycoprotein IIIa polymorphisms and the risk of premature myocardial infarction
40. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples
41. Vailidity of post-mortem alcohol reports
42. Reliability of data on smoking habit and coffee drinking collected by personal interview in a hospital-based case-control study
43. The agreement between self-reporting and clinical diagnosis for selected medical conditions among the elderly in Taiwan
44. The validity of self-reported hypertension and correlates of hypertension awareness among blacks and whites within the stroke belt
45. Risk factors and triggers of sudden death in the working generation: An autopsy proven case-control study
46. Relation of a postmortem renal index of hypertension to atherosclerosis in youth. The pathobiological determinants of atherosclerosis in youth (PDAY) research group
47. Nephosclerosis, glycohemoglobin, cholesterol, and smoking in subjects dying of coronary heart disease
48. Platelet alloantigens HPA-1, -2, -3, -5 and -6 in Finns
49. A1/A2 polymorphism and sudden cardiac death
50. A polymorphism in the progression of abdominal aortic atherosclerosis
51. Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque
52. Oral platelet glycoprotein IIb/IIIa antagonist decreased intimal thickening after arterial injury in hypercholesterolemic apolipoprotein E knockout mice
53. Reduction in atherosclerotic lesion size in pigs by αvβ3 inhibitors is associated with inhibition of insulin-like growth factor-1-mediated signaling
54. Blocking ligand occupancy of the αvβ3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells
55. Integrin signaling
56. Activation of integrin αvβ3 regulates cell adhesion and migration to bone sialoprotein
57. The synergistic activity of α- v β3 integrin and PDGF receptor increases cell migration